Pacific Shuanglin Bio-pharmacy Co., Ltd. (SHE:000403)
China · Delayed Price · Currency is CNY 10.03
-0.30 (-2.90%)
Sep 11, 2026, 3:04 PM CST
SHE:000403 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 2,476 | 2,633 | 2,655 | 2,329 | 2,405 | 1,972 |
Revenue Growth | -1.16% | -0.83% | 14.00% | -3.18% | 21.98% | 87.80% |
Gross Profit Gross Profit Growth | 893.27 | 1,089 | 1,303 | 1,199 | 1,254 | 907.93 |
Operating Income Operating Income Growth | 390.53 | 563.97 | 793.13 | 633.7 | 587.01 | 430.2 |
Net Income Net Income Growth | 267.77 | 419.27 | 745.32 | 612.11 | 587.13 | 391.06 |
Earnings Per Share EPS Growth | 0.28 | 0.44 | 0.78 | 0.65 | 0.62 | 0.43 |
EPS Growth | -59.21% | -43.59% | 20.71% | 4.60% | 45.23% | 45.78% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Pharmaceutical Industry Pharmaceutical Industry Growth | 2,475 | 2,631 | 2,654 | 2,325 | 2,396 | 1,966 |
Unallocated Others Unallocated Others Growth | 1.24 | 1.14 | 1.05 | 3.27 | 9.59 | 5.27 |
Total Total Growth | 2,476 | 2,633 | 2,655 | 2,329 | 2,405 | 1,972 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 1,072 | 1,025 | 1,604 | 1,853 | 1,423 | 1,120 |
Total Debt Total Debt Growth | 1,201 | 804.06 | 654.44 | 496.02 | 373.36 | 141.46 |
Net Cash (Debt) Net Cash Growth | -128.79 | 220.48 | 949.39 | 1,357 | 1,050 | 978.42 |
Net Cash Growth | - | -76.78% | -30.02% | 29.22% | 7.30% | - |
Net Cash Per Share Net Cash Per Share Growth | -0.14 | 0.23 | 0.99 | 1.43 | 1.10 | 1.06 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -107.2 | -215.99 | 321.79 | 679.01 | 524.22 | 408.22 |
Capital Expenditures CapEx Growth | -225.33 | -333.4 | -520.71 | -377.27 | -378.64 | -326.16 |
Free Cash Flow Free Cash Flow Growth | -332.53 | -549.39 | -198.92 | 301.74 | 145.58 | 82.06 |
Free Cash Flow Growth | - | - | - | 107.27% | 77.41% | -46.94% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 36.08% | 41.37% | 49.08% | 51.48% | 52.13% | 46.05% |
Operating Margin | 15.77% | 21.42% | 29.88% | 27.21% | 24.41% | 21.82% |
Pretax Margin | 13.34% | 19.00% | 32.12% | 29.55% | 27.46% | 23.23% |
Profit Margin | 10.81% | 15.93% | 28.08% | 26.28% | 24.41% | 19.83% |
FCF Margin | -13.43% | -20.87% | -7.49% | 12.96% | 6.05% | 4.16% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.300 | - | 0.385 | 0.154 | 0.062 | 0.043 |
Dividend Per Share Growth | - | - | 150.06% | 149.27% | 43.16% | - |
Dividend Yield | 2.90% | - | 2.40% | 0.76% | 0.36% | 0.21% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 36.63 | 31.03 | 20.73 | 32.60 | 28.39 | 52.52 |
Forward PE | 7.49 | 11.50 | 16.77 | 30.96 | 20.90 | 36.40 |
P/FCF Ratio | - | - | - | 66.14 | 114.50 | 250.30 |
PS Ratio | 3.91 | 4.94 | 5.82 | 8.57 | 6.93 | 10.42 |